What is ADMA Biologics's net margin?

ADMA Biologics (ADMA) reported net margin of 32.4% in Q1 2026.

How has ADMA Biologics's net margin changed year-over-year?

ADMA Biologics's net margin decreased by 27.9% year-over-year, from 45% to 32.4%.

What is the long-term trend for ADMA Biologics's net margin?

Over 5 years (2020 to 2025), ADMA Biologics's net margin has grown at a -30.6% compound annual growth rate (CAGR), from -179.4% to 28.8%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

ADMA Biologics ADMA Net margin

Net margin at other companies

AbCellera Biologics Inc.ABCL

-181.7%-77.9pp

AnaptysBio, Inc.ANAB

-49.9%-22.6pp

ZymeworksZYME

-126.3%+5.0pp

Bio-Rad LaboratoriesBIO

6.5%+3.4pp

Quest DiagnosticsDGX

9.1%+0.2pp

AbbVieABBV

5.8%-1.5pp

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Calculated from ADMA Biologics’s reported figures.

net income/total revenue=32.4%

Based on trailing twelve months.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's net margin?: ADMA Biologics (ADMA) reported net margin of 32.4% in Q1 2026.
How has ADMA Biologics's net margin changed year-over-year?: ADMA Biologics's net margin decreased by 27.9% year-over-year, from 45% to 32.4%.
What is the long-term trend for ADMA Biologics's net margin?: Over 5 years (2020 to 2025), ADMA Biologics's net margin has grown at a -30.6% compound annual growth rate (CAGR), from -179.4% to 28.8%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.